Sara Solar
Foot & Ankle Surgery · Irvine, CANPI 1720578107
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (54.5%), food and beverage and education — rather than concentrated in one kind of arrangement. 20 manufacturers reported payments, led by Stryker at 56.3% of the total. Reporting peaked in 2022 at $7,695 and has fallen 91.1% since, to $681 in 2025.
Across 112 payments — averaging $118.37 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$7K
- Treace Medical Concepts, Inc.$2K
- Integra Lifesciences Corporation$2K
- Saxum Surgical, Inc.$1K
- Smith+Nephew$197
- Seapearl East, Inc$120
- plus $713 from 14 others
What the payments were for
- Travel & lodging$7,22254%
- Food & beverage$4,83636%
- Education$1,2009%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 61 | $7,464 |
| Treace Medical Concepts, Inc. | 2 | $1,904 |
| Integra Lifesciences Corporation | 23 | $1,659 |
| Saxum Surgical, Inc. | 1 | $1,200 |
| Smith+Nephew | 5 | $197 |
| Seapearl East, Inc | 1 | $120 |
| Zimmer Biomet | 1 | $100 |
| Inari Medical, Inc. | 2 | $84 |
| Biotissue Holdings Inc. | 2 | $81 |
| Paragon 28, Inc. | 1 | $80 |
| Medartis Inc. | 1 | $71 |
| Paratek Pharmaceuticals, Inc. | 3 | $50 |
| Johnson & Johnson | 1 | $49 |
| Bioventus LLC | 2 | $45 |
| Tactile Systems Technology Inc | 1 | $35 |
| AbbVie | 1 | $26 |
| Ossdsign USA Incorporated | 1 | $24 |
| Access Pro Medical, LLC | 1 | $24 |
| Medtronic | 1 | $24 |
| Polynovo North America LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROstep$3,739
- INTEGRA$3,183
- Lapiplasty System$1,817
- AUGMENT INJECTABLE$1,174
- PROPHECY$1,134
- INTEGRA DERMAL REGENERATION TEMPLATE$1,016
- PRIMATRIX$1,016
- INBONE$871
- INVISION$871
- ANCHORAGE$172
- OMNIGRAFT$134
- CITREFIX$116
- STRAVIX MESH$112
How this compares
$13,258 in reported general payments places this provider in the 85th percentile of 1,126 foot & ankle surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JubliaEfinaconazole | 23 | $17,542 |
| Ciclopirox | 67 | $1,083 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 42 | $750 |
| Diclofenac Sodium | 14 | $346 |
| Cephalexin | 11 | $38 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Irvine
- Eboni VincentIrvine$54K
- Andrew EskanderIrvine$30K
- Eric GizaSacramento$3.6M
- Thomas HarrisPasadena$3M
- Thomas ChangSanta Rosa$2M
- Michael CoughlinSan Francisco$1.6M
- Vladimir ZeetserEncino$677K
- Jason NowakRedding$526K
- Candice BradyCamarillo$462K
- Andrew HsuOrange$456K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.